hotspot -WSS

hotspot

author：hotspot 2025-10-01 07:42:01 - browse：5946

Sen. Ron Wyden, D-Ore., left, and Sen. Mike Crapo, R-Idaho, right, walk on Capitol Hill. -- health policy coverage from STAT — Sen. Ron Wyden, D-Ore., left, and Sen. Mike Crapo, R-Idaho, right, walk on Capitol Hill in 2021. Susan Walsh/AP

WASHINGTON — One of the top health care committees in the Senate is assembling ideas for bipartisan legislation to address drug shortages, three Senate aides and three lobbyists told STAT.

The talks, led by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) are in the early days, but they could move the debate over drug shortage reforms into a new phase. The committee has jurisdiction over Medicare and Medicaid payment policies for hospitals. Other committees that have tried tackling the issue have jurisdiction mostly over the Food and Drug Administration.

The panel is tentatively aiming to hold a hearing on the issue in November, the sources said. The panel has also started accepting input from outside stakeholders, one lobbyist said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： World's first CRISPR

explore

entertainment

WSS

Intercept Pharmaceuticals sells itself for less than $1 billion

Biogen shutters digital health group, ends Apple study, in cost cutting move

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Weight loss drug costs may need more research, senator suggests

World's first CRISPR

hotspot

hotspot

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

Sudafed saga points to U.S. issues with evaluating older drugs

At least 13 dead in Texas as scorching temps continue

Researchers use wearables data and AI to predict preterm birth risk

In age of alternative facts, a scholarly course on calling out crap

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Medicare details structure of new drug price negotiation program

Medicare drug price negotiation program allowed for now

Psychedelics group wrestles with new pharma identity

Childhood cancer progress stalls for Black, Hispanic kids: Report

explore

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Ionis has late

World's first CRISPR

Ransomware attacks on hospitals: Study outlines patient impact

Sudafed saga points to U.S. issues with evaluating older drugs

Poor hospice wound care hurts patients and families

explore

entertainment

focus

focus